CN115867271A - 术后恶心和呕吐的疗法 - Google Patents

术后恶心和呕吐的疗法 Download PDF

Info

Publication number
CN115867271A
CN115867271A CN202180047918.XA CN202180047918A CN115867271A CN 115867271 A CN115867271 A CN 115867271A CN 202180047918 A CN202180047918 A CN 202180047918A CN 115867271 A CN115867271 A CN 115867271A
Authority
CN
China
Prior art keywords
amisulpride
use according
patient
patients
vomiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180047918.XA
Other languages
English (en)
Chinese (zh)
Inventor
J·C·吉尔伯特
G·福克斯
R·W·格雷斯特伍德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acacia Pharma Ltd
Original Assignee
Acacia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB2010361.0A external-priority patent/GB202010361D0/en
Priority claimed from GBGB2108238.3A external-priority patent/GB202108238D0/en
Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd
Publication of CN115867271A publication Critical patent/CN115867271A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202180047918.XA 2020-07-06 2021-07-06 术后恶心和呕吐的疗法 Pending CN115867271A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2010361.0 2020-07-06
GBGB2010361.0A GB202010361D0 (en) 2020-07-06 2020-07-06 Therapy of post-operative nausea and vomiting
GBGB2108238.3A GB202108238D0 (en) 2021-06-09 2021-06-09 Thearpy of post-operative nausea and vomiting
GB2108238.3 2021-06-09
PCT/GB2021/051720 WO2022008901A1 (en) 2020-07-06 2021-07-06 Therapy of post-operative nausea and vomiting

Publications (1)

Publication Number Publication Date
CN115867271A true CN115867271A (zh) 2023-03-28

Family

ID=77021661

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180047918.XA Pending CN115867271A (zh) 2020-07-06 2021-07-06 术后恶心和呕吐的疗法

Country Status (11)

Country Link
US (1) US20230263770A1 (https=)
EP (1) EP4175631A1 (https=)
JP (1) JP2023538216A (https=)
KR (1) KR20230035095A (https=)
CN (1) CN115867271A (https=)
AU (1) AU2021305446A1 (https=)
BR (1) BR112023000167A2 (https=)
CA (1) CA3187665A1 (https=)
IL (1) IL299649A (https=)
MX (1) MX2023000283A (https=)
WO (1) WO2022008901A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250152595A1 (en) * 2023-11-09 2025-05-15 Lisa Myslinski Medication to alleviate nausea with or without vomiting, vertigo, and pain

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102892407A (zh) * 2010-03-11 2013-01-23 阿卡西亚制药有限公司 氨磺必利作为止吐药的用途
CN110035748A (zh) * 2016-11-01 2019-07-19 阿卡西亚制药有限公司 用氨磺必利的术后呕吐的疗法
CN110603036A (zh) * 2017-02-10 2019-12-20 阿卡西亚制药有限公司 术后恶心和呕吐的补救治疗

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102892407A (zh) * 2010-03-11 2013-01-23 阿卡西亚制药有限公司 氨磺必利作为止吐药的用途
CN110035748A (zh) * 2016-11-01 2019-07-19 阿卡西亚制药有限公司 用氨磺必利的术后呕吐的疗法
CN110603036A (zh) * 2017-02-10 2019-12-20 阿卡西亚制药有限公司 术后恶心和呕吐的补救治疗

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
P.KRANKE: "I.V.APD42l(amisulpride)prevents postoperative nausea and vomiting:a randomized, double-blind, placebo-controlled, multicentre trial", 《BRITISH JOURNAL OF ANAESTHESIA》, vol. 111, no. 6, 19 July 2013 (2013-07-19), pages 938 - 945, XP055271509, DOI: 10.1093/bja/aet251 *

Also Published As

Publication number Publication date
CA3187665A1 (en) 2022-01-13
US20230263770A1 (en) 2023-08-24
JP2023538216A (ja) 2023-09-07
EP4175631A1 (en) 2023-05-10
AU2021305446A1 (en) 2023-02-02
MX2023000283A (es) 2023-02-09
BR112023000167A2 (pt) 2023-01-31
KR20230035095A (ko) 2023-03-10
WO2022008901A1 (en) 2022-01-13
IL299649A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
JP7526244B2 (ja) 術後悪心嘔吐の救援治療
US20240050403A1 (en) Therapy of post-operative emesis with amisulpride
CN115867271A (zh) 术后恶心和呕吐的疗法
HK40091212A (zh) 术後恶心和呕吐的疗法
EA048577B1 (ru) Терапия послеоперационной тошноты и рвоты
HK40005558A (en) Therapy of post-operative emesis with amisulpride
EA044539B1 (ru) Терапия постоперационной рвоты амисульпридом
JPWO2018146490A5 (https=)
CA3052535C (en) Rescue treatment of post operative nausea and vomiting
NZ792875A (en) Therapy of post-operative emesis with amisulpride
HK40013552A (en) Rescue treatment of post operative nausea and vomiting
EA042759B1 (ru) Экстренное лечение постоперационной тошноты и рвоты

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40091212

Country of ref document: HK